Titan Pharmaceuticals, Inc.

Navigate Titan Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Who We Are
    • Strategic Alliances
    • IP Portfolio
    • Management Team
    • Board of Directors
    • Careers
  • Technology
  • Pipeline
    • Overview
    • Probuphine
    • Ropinirole Implant
    • T3 Implant
  • News
    • Overview
    • Press Releases
    • Events
    • Presentations
    • In the News
    • Publications
    • Posters
    • Media Resources
  • Investors
    • Investor Relations
    • Overview
    • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
    • Company Info
    • Company Information
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
    • Financial Info
    • Financials
    • Financial Results
    • Stock Data
    • Quote
    • Charts
    • Historical Data
    • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact
  • Search

Press Releases

  • Home
  • News
  • Press Releases
News

Navigate News

  • Overview
  • Press Releases
  • Events
  • Presentations
  • In the News
  • Publications
  • Posters
  • Media Resources

Press Releases

  • All News
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2017 Financial Results

April 2, 2018

Titan Pharmaceuticals Schedules Conference Call To Review Fourth Quarter And Full Year 2017 Financial Results

March 26, 2018

Titan Executes Agreement For Acquisition By Molteni Of Probuphine® In Europe And Other Select Territories

March 21, 2018

Titan Announces Amendment To Horizon Loan Agreement

February 2, 2018

Titan In Discussions With Braeburn Regarding U.S. Probuphine® Commercialization

January 22, 2018

Titan Pharmaceuticals Partners With Molteni To Market Probuphine® In Europe

November 28, 2017

European Medicines Agency Accepts Titan Pharmaceuticals' Marketing Authorization Application For Probuphine®

November 27, 2017

Titan Pharmaceuticals Reports Third Quarter 2017 Financial Results

November 9, 2017

Titan Pharmaceuticals Schedules Conference Call To Review Third Quarter 2017 Financial Results

November 3, 2017

Titan Pharmaceuticals Presents Non-Clinical Data From Liothyronine (L-T3) Implant Studies

October 19, 2017

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...16
  • Next »
© 2018 Titan Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap